Mauro Magnani Selected Research

Adjuvant Chemotherapy

1/2020	Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
1/2019	Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
11/2014	Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
5/2005	Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro Magnani Research Topics

Disease

32	Neoplasms (Cancer) 03/2024 - 05/2003
25	Infections 12/2023 - 09/2002
20	Stomach Neoplasms (Stomach Cancer) 09/2023 - 11/2002
12	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2024 - 11/2012
12	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 04/2007
10	Virus Diseases (Viral Diseases) 01/2024 - 04/2002
8	Breast Neoplasms (Breast Cancer) 01/2017 - 07/2003
7	Inflammation (Inflammations) 06/2020 - 07/2011
6	Viremia 12/2019 - 10/2007
6	Disease Progression 06/2016 - 10/2002
5	Leishmaniasis 04/2024 - 10/2014
5	Neoplasm Metastasis (Metastasis) 07/2020 - 12/2008
4	Phenylketonurias (Phenylketonuria) 01/2023 - 11/2014
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 01/2015
4	Carcinoma (Carcinomatosis) 10/2018 - 05/2004
4	Acquired Immunodeficiency Syndrome (AIDS) 12/2009 - 10/2002
3	Leukemia 01/2024 - 01/2005
3	Communicable Diseases (Infectious Diseases) 03/2021 - 01/2014
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 11/2014
3	Human Influenza (Influenza) 05/2019 - 08/2011
3	Murine Acquired Immunodeficiency Syndrome (MAIDS) 01/2016 - 10/2002
3	Melanoma (Melanoma, Malignant) 11/2015 - 01/2012
3	Ulcerative Colitis 08/2013 - 06/2005
3	Triple Negative Breast Neoplasms 05/2013 - 03/2011
2	COVID-19 12/2023 - 03/2022
2	Hypoxia (Hypoxemia) 07/2023 - 03/2023
2	Guanidinoacetate methyltransferase deficiency 06/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 06/2007
2	Invasive Fungal Infections 01/2021 - 01/2019
2	Intellectual Disability (Idiocy) 01/2021 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 01/2021 - 08/2011
2	Adenocarcinoma 11/2020 - 07/2020
2	Atherosclerosis 01/2019 - 06/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2017 - 11/2014

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2002
16	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2002
15	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 07/2004
9	VaccinesIBA 01/2023 - 04/2002
6	CytokinesIBA 12/2023 - 09/2009
6	Messenger RNA (mRNA)IBA 11/2023 - 08/2014
6	GlucocorticoidsIBA 12/2021 - 07/2004
6	indole-3-carbinolIBA 01/2015 - 07/2003
6	Cadherins (E-Cadherin)IBA 05/2008 - 11/2002
5	Immunoglobulin G (IgG)IBA 01/2023 - 10/2018
5	Glutathione (Reduced Glutathione)IBA 01/2021 - 04/2007
5	Fluorouracil (Carac)FDA LinkGeneric 07/2020 - 05/2005
5	glutathione-C4IBA 05/2019 - 08/2011
5	Cetuximab (Erbitux)FDA Link 01/2012 - 03/2008
4	Protein Isoforms (Isoforms)IBA 03/2024 - 06/2007
4	CEACAM1 ProteinIBA 01/2024 - 01/2012
4	Sulfhydryl Compounds (Thiols)IBA 01/2024 - 08/2014
4	EnzymesIBA 07/2023 - 09/2010
4	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020 - 02/2009
4	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 04/2006
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2020 - 04/2007
4	RNA (Ribonucleic Acid)IBA 12/2019 - 10/2007
4	SteroidsIBA 06/2015 - 06/2005
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2012 - 03/2008
4	Estrogen ReceptorsIBA 01/2012 - 07/2003
3	AntioxidantsIBA 07/2023 - 01/2014
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 01/2014
3	Antiviral Agents (Antivirals)IBA 08/2020 - 11/2002
3	XELOXIBA 01/2020 - 11/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2019 - 01/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 05/2013
3	dexamethasone 21-phosphate FDA LinkGeneric 08/2013 - 07/2004
3	Hormones (Hormone)IBA 05/2013 - 03/2011
3	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 10/2002
3	ErbB Receptors (EGF Receptor)IBA 01/2012 - 03/2008
3	Thymidylate SynthaseIBA 04/2007 - 12/2004
2	Cysteamine (Mercaptamine)FDA Link 01/2024 - 12/2020
2	Cell Adhesion MoleculesIBA 01/2024 - 01/2014
2	Proteasome InhibitorsIBA 09/2023 - 01/2017
2	Lamin Type A (Lamin A)IBA 01/2023 - 12/2021
2	TunicamycinIBA 06/2022 - 01/2016
2	CreatineIBA 06/2022 - 01/2021
2	glycocyamineIBA 06/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2022 - 12/2021
2	NF-kappa B (NF-kB)IBA 03/2021 - 02/2015
2	SolutionsIBA 01/2021 - 08/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2020
2	Monoclonal AntibodiesIBA 01/2021 - 02/2010
2	Cysteine (L-Cysteine)FDA Link 12/2020 - 05/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 07/2020
2	RamucirumabIBA 11/2020 - 07/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2007
2	InterleukinsIBA 12/2019 - 08/2014
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2019 - 11/2012
2	p38 Mitogen-Activated Protein KinasesIBA 01/2019 - 01/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2013
2	Diphosphonates (Bisphosphonates)IBA 10/2018 - 01/2014

Therapy/Procedure

26	Therapeutics 04/2024 - 10/2002
11	Drug Therapy (Chemotherapy) 11/2023 - 05/2004
4	Adjuvant Chemotherapy 01/2020 - 05/2005
3	Highly Active Antiretroviral Therapy (HAART) 04/2015 - 10/2007
2	Immunotherapy 11/2023 - 01/2016
2	Bioreactors (Bioreactor) 01/2020 - 01/2019